LAROSA JOSEPH J — SEC insider filings

SEC reporting owner CIK 1238303. 28 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-08-31 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)EVP General Counsel and Secret28—28 legs · 32,920 sh · $25,438,21257

Insider filings — LAROSA JOSEPH J

FiledFormIssuerReported transactionsSource
2026-11-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 12,283 @ $381.92 · Tax withholding (F): 8,686 @ $950.50 · Sale (S): 3,939 @ $965.41 · Sale (S): 527 @ $966.11 · Option exercise (M): 12,283 (derivative) @ $0EDGAR
2026-08-214REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 12,282 @ $381.92 · Tax withholding (F): 9,019 @ $830.15 · Option exercise (M): 12,282 (derivative) @ $0EDGAR
2025-12-094REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 2,476 @ $0 · Tax withholding (F): 1,396 @ $712.94 · Grant/award (A): 12,210 (derivative) @ $0EDGAR
2025-11-244REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 14,450 @ $555.67 · Tax withholding (F): 12,686 @ $736.77 · Option exercise (M): 14,450 (derivative) @ $0EDGAR
2024-12-184REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 702 @ $730.81EDGAR
2024-12-104REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 2,332 @ $0 · Tax withholding (F): 492 @ $787 · Grant/award (A): 8,981 (derivative) @ $0EDGAR
2024-07-124REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,866 @ $1,088.95EDGAR
2024-06-254REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 14,450 @ $555.67 · Tax withholding (F): 11,084 @ $1,060.13 · Option exercise (M): 14,450 (derivative) @ $0EDGAR
2024-06-124REGENERON PHARMACEUTICALS, INC. (REGN)Gift (G): 1,608 @ $0EDGAR
2024-05-224REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,865 @ $994.90EDGAR
2024-02-284REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,000 @ $990EDGAR
2024-02-264REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,000 @ $967.65EDGAR
2024-02-094REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 1,000 @ $950EDGAR
2024-01-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 34,000 @ $399.66 · Tax withholding (F): 24,493 @ $912.30 · Option exercise (M): 34,000 (derivative) @ $0EDGAR
2023-12-124REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 852 @ $843.79 · Grant/award (A): 2,133 @ $0 · Tax withholding (F): 669 @ $844.09 · Grant/award (A): 7,649 (derivative) @ $0EDGAR
2023-03-274REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 10,000 @ $270.43 · Tax withholding (F): 6,742 @ $801.59 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-03-144REGENERON PHARMACEUTICALS, INC. (REGN)Gift (G): 1,006 @ $0EDGAR
2022-12-204REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 2,752 @ $0 · Grant/award (A): 10,159 (derivative) @ $0EDGAR
2022-12-134REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 492 @ $753.28EDGAR
2022-09-124REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 30,000 @ $270.43 · Tax withholding (F): 20,730 @ $730.96 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2022-04-114REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 5,114 @ $721.10EDGAR
2022-04-044REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 369 @ $685.71 · Sale (S): 557 @ $686.26 · Sale (S): 497 @ $687.41 · Sale (S): 799 @ $688.59 · Sale (S): 218 @ $689.43 · Sale (S): 250 @ $690.51 · +9 moreEDGAR
2021-12-144REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 697 @ $664.34EDGAR
2021-12-104REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 3,338 @ $0 · Option exercise (M): 30,000 @ $179.13 · Tax withholding (F): 19,772 @ $657.11 · Option exercise (M): 30,000 (derivative) @ $0 · Grant/award (A): 14,253 (derivative) @ $0EDGAR
2021-08-244REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,575 @ $664.85 · Sale (S): 3,383 @ $661.80 · Sale (S): 41 @ $665.40 · Sale (S): 1 @ $666.22 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-07-074REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,602 @ $582.20 · Sale (S): 3,398 @ $580 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-12-114REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 1,930 @ $0 · Grant/award (A): 19,950 (derivative) @ $0EDGAR
2020-08-314REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 6,000 @ $52.03 · Tax withholding (F): 3,197 @ $614.87 · Option exercise (M): 4,000 @ $52.03 · Tax withholding (F): 2,131 @ $614.87 · Sale (S): 4,672 @ $615.04 · Option exercise (M): 6,000 (derivative) @ $0 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1238303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs